Cover and table of contents

10K characters. Original on sec.gov · Markdown

Cover and table of contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______

Commission file number 1-11353

LABCORP HOLDINGS INC.

(Exact name of registrant as specified in its charter)


Delaware						99-2588107
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)


358 South Main Street
Burlington	,	North Carolina	27215
(Address of principal executive offices)			(Zip Code)

(Registrant’s telephone number, including area code) 336-229-1127

Securities registered pursuant to Section 12(b) of the Act:


Title of each class						Trading Symbol						Name of exchange on which registered
Common Stock, $0.10 par value						LH						New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 4, 2026, there were 81.1 million shares of the registrant’s common stock, $0.10 par value, outstanding.

TABLE OF CONTENTS


		Page

Commonly Used Abbreviations		2

Part I. Financial Information

Item 1.	Financial Statements	3

	Condensed Consolidated Balance Sheets (Unaudited)	3

	Condensed Consolidated Statements of Operations (Unaudited)	4

	Condensed Consolidated Statements of Comprehensive Earnings (Unaudited)	5

	Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited)	6

	Condensed Consolidated Statements of Cash Flows (Unaudited)	7

	Notes to the Condensed Consolidated Financial Statements (Unaudited)	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	24

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	33

Item 4.	Controls and Procedures	34

Part II. Other Information


Item 1.	Legal Proceedings	35

Item 1A.	Risk Factors	35

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	35

Item 3.	Defaults Upon Senior Securities	35

Item 4.	Mine Safety Disclosures	35

Item 5.	Other Information	35

Item 6.	Exhibits	36

	Signatures	37

COMMONLY USED ABBREVIATIONS


The abbreviations listed below may be commonly used in this report.

AMCA						American Medical Collection Agency
Annual Report						Annual Report on Form 10-K for the fiscal year ended December 31, 2025
AR Facility						accounts receivable securitization facility
ASU						Accounting Standards Update
BLS						Biopharma Laboratory Services
Board						board of directors of Labcorp Holdings Inc.
CODM						chief operating decision maker
Common Stock						common stock, par value $0.10 per share
CRO						contract research organization
DCP						deferred compensation plan
DOJ						U.S. Department of Justice
Dx						Diagnostics Laboratories
ED						Early Development Research Laboratories
EPS						earnings per share
FASB						Financial Accounting Standards Board
Fortrea						Fortrea Holdings Inc.
GAAP						U.S. generally accepted accounting principles
LCAH						Laboratory Corporation of America Holdings
MCO						managed care organization
N/A						not applicable
OBBBA						One Big Beautiful Bill Act
OCR						U.S. Office of Civil Rights
PSC						patient service center
S&P						Standard & Poor’s
SEC						U.S. Securities and Exchange Commission
SG&A						selling, general, and administrative expenses
SOFR						secured overnight financing rate
Spin-off						June 2023 spin-off of Fortrea
SPV						special purpose vehicle
2026 Term Loan						term loan credit agreement entered on March 20, 2026
TSA						transition services agreement with Fortrea
U.K.						United Kingdom
U.S.						United States of America
USD						U.S. Dollar

PART I. FINANCIAL INFORMATION

Next: Item 1. FINANCIAL STATEMENTS